Skip to contentC
Chemed Corp
C
CHEChemed Corp Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$348.60M$348.60Mderived−5.4% vs Q4 2012 Net Income$22.91M$22.91Mderived−14.3% vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$39,440,000−14.2% Operating Cash Flowderived$14,989,000−72.5% Free Cash Flowderived$4,552,000−90.0% Margins · derivedOperating margin11.3%−1.2 pt vs Q4 2012
Net margin6.6%−0.7 pt vs Q4 2012
ended Dec 31, 2013 · filed Feb 27, 2014 · 58 d after period end